These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 25909284)

  • 21. FGFR inhibitor AZD4547 can enhance sensitivity of esophageal squamous cell carcinoma cells with epithelial‑mesenchymal transition to gefitinib.
    Luo H; Quan J; Xiao H; Luo J; Zhang Q; Pi G; Ye Y; He R; Liu Y; Su X; Zhao L; Wang G
    Oncol Rep; 2018 May; 39(5):2270-2278. PubMed ID: 29517107
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Establishment and characterization of esophageal squamous cell carcinoma patient-derived xenograft mouse models for preclinical drug discovery.
    Zhang J; Jiang D; Li X; Lv J; Xie L; Zheng L; Gavine PR; Hu Q; Shi Y; Tan L; Ge D; Xu S; Li L; Zhu L; Hou Y; Wang Q
    Lab Invest; 2014 Aug; 94(8):917-26. PubMed ID: 24999713
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Targeting MCL-1 sensitizes human esophageal squamous cell carcinoma cells to cisplatin-induced apoptosis.
    Yu X; Li W; Xia Z; Xie L; Ma X; Liang Q; Liu L; Wang J; Zhou X; Yang Y; Liu H
    BMC Cancer; 2017 Jun; 17(1):449. PubMed ID: 28659182
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Anti-tumour effects of a macrolide analog F806 in oesophageal squamous cell carcinoma cells by targeting and promoting GLUT1 autolysosomal degradation.
    Li X; Li L; Wu X; Wen B; Lin W; Cao Y; Xie L; Zhang H; Dong G; Li E; Xu L; Cheng Y
    FEBS J; 2022 Nov; 289(21):6782-6798. PubMed ID: 35653269
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Apollon modulates chemosensitivity in human esophageal squamous cell carcinoma.
    Zhang S; Tang W; Weng S; Liu X; Rao B; Gu J; Chen S; Wang Q; Shen X; Xue R; Dong L
    Oncotarget; 2014 Aug; 5(16):7183-97. PubMed ID: 25216531
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Assessment of insulin-like growth factor 1 receptor as an oncogene in esophageal squamous cell carcinoma and its potential implication in chemotherapy.
    Ma W; Zhang T; Pan J; Shi N; Fan Q; Wang L; Lu SH
    Oncol Rep; 2014 Oct; 32(4):1601-9. PubMed ID: 25175038
    [TBL] [Abstract][Full Text] [Related]  

  • 27. miR-1 suppresses the growth of esophageal squamous cell carcinoma in vivo and in vitro through the downregulation of MET, cyclin D1 and CDK4 expression.
    Jiang S; Zhao C; Yang X; Li X; Pan Q; Huang H; Wen X; Shan H; Li Q; Du Y; Zhao Y
    Int J Mol Med; 2016 Jul; 38(1):113-22. PubMed ID: 27247259
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ixazomib Induces Apoptosis and Suppresses Proliferation in Esophageal Squamous Cell Carcinoma through Activation of the c-Myc/NOXA Pathway.
    Wang T; Zhang P; Chen L; Qi H; Chen H; Zhu Y; Zhang L; Zhong M; Shi X; Li Q
    J Pharmacol Exp Ther; 2022 Jan; 380(1):15-25. PubMed ID: 34740946
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The CADM2/Akt pathway is involved in the inhibitory effect of miR-21-5p downregulation on proliferation and apoptosis in esophageal squamous cell carcinoma cells.
    Li X; Chen D; Li M; Gao X; Shi G; Zhao H
    Chem Biol Interact; 2018 May; 288():76-82. PubMed ID: 29680210
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pristimerin targeting NF-κB pathway inhibits proliferation, migration, and invasion in esophageal squamous cell carcinoma cells.
    Tu Y; Tan F; Zhou J; Pan J
    Cell Biochem Funct; 2018 Jun; 36(4):228-240. PubMed ID: 29781107
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cancer-associated fibroblasts mediated chemoresistance by a FOXO1/TGFβ1 signaling loop in esophageal squamous cell carcinoma.
    Zhang H; Xie C; Yue J; Jiang Z; Zhou R; Xie R; Wang Y; Wu S
    Mol Carcinog; 2017 Mar; 56(3):1150-1163. PubMed ID: 27769097
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A dual mTORC1 and mTORC2 inhibitor shows antitumor activity in esophageal squamous cell carcinoma cells and sensitizes them to cisplatin.
    Huang Y; Xi Q; Chen Y; Wang J; Peng P; Xia S; Yu S
    Anticancer Drugs; 2013 Oct; 24(9):889-98. PubMed ID: 23838676
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Macrophage inhibitory factor 1 acts as a potential biomarker in patients with esophageal squamous cell carcinoma and is a target for antibody-based therapy.
    Wang XB; Jiang XR; Yu XY; Wang L; He S; Feng FY; Guo LP; Jiang W; Lu SH
    Cancer Sci; 2014 Feb; 105(2):176-85. PubMed ID: 24383865
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of the effect of p65 siRNA and curcumin in promoting apoptosis in esophageal squamous cell carcinoma cells and in nude mice.
    Tian F; Zhang C; Tian W; Jiang Y; Zhang X
    Oncol Rep; 2012 Jul; 28(1):232-40. PubMed ID: 22552693
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Metformin promotes autophagy and apoptosis in esophageal squamous cell carcinoma by downregulating Stat3 signaling.
    Feng Y; Ke C; Tang Q; Dong H; Zheng X; Lin W; Ke J; Huang J; Yeung SC; Zhang H
    Cell Death Dis; 2014 Feb; 5(2):e1088. PubMed ID: 24577086
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Knockdown of frizzled-7 inhibits cell growth and metastasis and promotes chemosensitivity of esophageal squamous cell carcinoma cells by inhibiting Wnt signaling.
    Liu X; Yan Y; Ma W; Wu S
    Biochem Biophys Res Commun; 2017 Aug; 490(3):1112-1118. PubMed ID: 28669726
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Galectin-3 knockdown increases gefitinib sensitivity to the inhibition of EGFR endocytosis in gefitinib-insensitive esophageal squamous cancer cells.
    Cui G; Cui M; Li Y; Liang Y; Li W; Guo H; Zhao S
    Med Oncol; 2015 Apr; 32(4):124. PubMed ID: 25788032
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Curcumin potentiates the antitumor effects of 5-FU in treatment of esophageal squamous carcinoma cells through downregulating the activation of NF-κB signaling pathway in vitro and in vivo.
    Tian F; Fan T; Zhang Y; Jiang Y; Zhang X
    Acta Biochim Biophys Sin (Shanghai); 2012 Oct; 44(10):847-55. PubMed ID: 23017833
    [TBL] [Abstract][Full Text] [Related]  

  • 39. RFT2 is overexpressed in esophageal squamous cell carcinoma and promotes tumorigenesis by sustaining cell proliferation and protecting against cell death.
    Jiang XR; Yu XY; Fan JH; Guo L; Zhu C; Jiang W; Lu SH
    Cancer Lett; 2014 Oct; 353(1):78-86. PubMed ID: 25045844
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Deguelin, an Aurora B Kinase Inhibitor, Exhibits Potent Anti-Tumor Effect in Human Esophageal Squamous Cell Carcinoma.
    Yu X; Liang Q; Liu W; Zhou L; Li W; Liu H
    EBioMedicine; 2017 Dec; 26():100-111. PubMed ID: 29129699
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.